AKT1 and neoplasm: Briefly, the achievements of the current research represent that CAF‐derived exosomes containing miR‐20a can promote chemoresistance and aggressive growth in recipient NSCLC tumour cells owing to the ability of this miRNA to modulate the PTEN/PI3K‐AKT signalling pathway (Figure 12).